(UroToday.com) At the 2021 Society of Nuclear Medicine & Molecular Imaging (SNMMI) Meeting’s Correlative Cross-Sectional and Molecular Imaging session, Dr. Michael Blake discussed CT and MRI appearances of adrenal lesions. The adrenal glands play a critical role in physiology and endocrinology, as well as being critical in oncologic staging. However, there is an increasing dilemma of […]
(UroToday.com) At the 2021 Society of Nuclear Medicine & Molecular Imaging (SNMMI) Meeting’s Correlative Cross-Sectional and Molecular Imaging session, Dr. Preeti Sukerkar discussed CT and MRI appearances of benign and malignant lesions in prostate cancer. Dr. Sukerkar notes that there are several important points to consider when assessing bone lesions, including the patient’s age, history, symptoms, […]
(UroToday.com) At the 2021 Society of Nuclear Medicine & Molecular Imaging (SNMMI) Meeting’s Correlative Cross-Sectional and Molecular Imaging session, Dr. Jeremie Calais discussed the characterization of bone lesions in prostate cancer patients with PET/CT imaging.
Christopher Wallis: Hello, and thank you for joining us for the UroToday Journal Club. Today we are discussing a recent paper entitled, Inhibition of hypoxia-inducible factor-2α in renal cell carcinoma with belzutifan: A phase one trial and biomarker analysis. I’m Chris Wallis, a Fellow in Urologic Oncology at Vanderbilt, and with me today is Zach […]
Christopher Wallis: Hello and thank you for joining us for this UroToday Journal Club. Today we are discussing a recent publication entitled, A prospective trial of abiraterone acetate plus prednisone in black and white men with metastatic castrate-resistant prostate cancer. I’m Chris Wallis, a Fellow in Urologic Oncology at Vanderbilt, and with me today is […]
Urinary stone disease refers to the deposition of crystals, most commonly calcium oxalate and calcium phosphate, within the kidneys and urinary system. While urinary stone disease is not classically thought of as a metabolic disorder, a positive association between urinary stone disease and adverse cardiovascular events (e.g., myocardial infarction) has been reported, with vascular calcifications […]
{{header-clinical-trials-navigation}} A Validation Study on the Impact of Decipher® Testing on Treatment Recommendations in African-American and Non-African American Men With Prostate Cancer (VANDAAM Study) Condition: Prostate Cancer Study Type: Observational Clinical Trials Identifier NCT 8-digits: NCT02723734 Sponsor: H. Lee Moffitt Cancer Center and Research Institute Phase: Eligibility: Age: minimum 18 Years maximum N/A Gender: Male […]
Renal medullary carcinomas (RMCs) are rare kidney cancers that occur in adolescents and young adults of African ancestry. Although RMC is associated with the sickle cell trait and somatic loss of the tumor suppressor, SMARCB1, the ancestral origins of RMC remain unknown.
We report our experience with next-generation sequencing to characterize the landscape of actionable genomic alterations in renal cell carcinoma (RCC). A query of our institutional clinical sequencing database (MSK-IMPACT) was performed which included tumor samples from 38,468 individuals across all cancer types.
Recent years have witnessed the advent of novel treatment options for metastatic renal cell carcinoma (mRCC), including combination therapies with immune checkpoint inhibitors. Herein, we conducted an up-to-date and comprehensive meta-analysis including recently published data of phase III clinical trials evaluating immune-based combinations in mRCC.
